Massimo Carraro
University of Padua
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Massimo Carraro.
Molecular Pharmaceutics | 2013
Andrea Mattarei; Michele Azzolini; Massimo Carraro; Nicola Sassi; Mario Zoratti; Cristina Paradisi; Lucia Biasutto
The pharmacological exploitation of resveratrol is hindered by rapid phase-II conjugative metabolism in enterocytes and hepatocytes. One approach to the solution of this problem relies on prodrugs. We report the synthesis and characterization as well as the assessment of in vivo absorption and metabolism of a set of prodrugs of resveratrol in which the OH groups are engaged in the formal (-OCH2OR) or the more labile acetal (-OCH(CH3)OR) linkages. As carrier group (R) of the prodrug, we have used short ethyleneglycol oligomers (OEG) capped by a terminal methoxy group: -O-(CH2CH2O)n-CH3 (n = 0, 1, 2, 3, 4, 6). These moieties are expected to exhibit, to a degree, the favorable properties of longer polyethyleneglycol (PEG) chains, while their relatively small size makes for a more favorable drug loading capacity. After administration of formal-based prodrugs to rats by oral gavage, significant concentrations of derivatives were measured in blood samples over several hours, in all cases except for n = 0. Absorption was maximal for n = 4. Complete deprotection to give resveratrol and its metabolites was however too slow to be of practical use. Administration of the acetal prodrug carrying tetrameric OEG chains resulted instead in the protracted presence of resveratrol metabolites in blood, consistent with a progressive regeneration of the parent molecule from the prodrug after its absorption. The results suggest that prodrugs of polyphenols based on the acetal bond and short ethyleneglycol oligomers of homogeneous size may be a convenient tool for the systemic delivery of the unconjugated parent compound.
Molecules | 2014
Andrea Mattarei; Massimo Carraro; Michele Azzolini; Cristina Paradisi; Mario Zoratti; Lucia Biasutto
Low bioavailability severely hinders exploitation of the biomedical potential of resveratrol. Extensive phase-II metabolism and poor water solubility contribute to lowering the concentrations of resveratrol in the bloodstream after oral administration. Prodrugs may provide a solution—protection of the phenolic functions hinders conjugative metabolism and can be exploited to modulate the physicochemical properties of the compound. We report here the synthesis and characterization of carbamate ester derivatives of resveratrol bearing on each nitrogen atom a methyl group and either a methoxy-poly(ethylene glycol)-350 (mPEG-350) or a butyl-glucosyl promoiety conferring high water solubility. Ex vivo absorption studies revealed that the butyl-glucosyl conjugate, unlike the mPEG-350 one, is able to permeate the intestinal wall. In vivo pharmacokinetics confirmed absorption after oral administration and showed that no hydrolysis of the carbamate groups takes place. Thus, sugar groups can be attached to resveratrol to obtain soluble derivatives maintaining to some degree the ability to permeate biomembranes, perhaps by facilitated or active transport.
Current Organic Chemistry | 2008
Mario Pagliaro; Rosaria Ciriminna; Massimo Carraro; Sandro Campestrini
Whether in supercritical CO2 or in organic solvent and using O2 or aqueous H2O2 as primary oxidants, the series of sol-gel entrapped TPAP hybrid silica gels is a versatile class of oxidation catalysts suitable for the highly selective conversion of alcohols to carbonyls. These materials are generally more stable and active than traditional polymersupported analogues. This report summarizes recent findings showing the large potential of this technology for synthetic
Chemistry: A European Journal | 2006
Rosaria Ciriminna; Peter Hesemann; Joël J. E. Moreau; Massimo Carraro; Sandro Campestrini; Mario Pagliaro
Tetrahedron Letters | 2004
Sandro Campestrini; Massimo Carraro; Rosaria Ciriminna; Mario Pagliaro; Umberto Tonellato
Biochimica et Biophysica Acta | 2012
Nicola Sassi; Lucia Biasutto; Andrea Mattarei; Massimo Carraro; Valentina Giorgio; Anna Citta; Paolo Bernardi; Spiridione Garbisa; Ildikò Szabò; Cristina Paradisi; Mario Zoratti
Journal of Applied Polymer Science | 2008
Valerio Causin; Massimo Carraro; Carla Marega; Roberta Saini; Sandro Campestrini; Antonio Marigo
Advanced Synthesis & Catalysis | 2005
Sandro Campestrini; Massimo Carraro; Rosaria Ciriminna; Mario Pagliaro; Umberto Tonellato
Journal of Molecular Catalysis A-chemical | 2007
L De Zan; Dana Gašparovičová; Milan Králik; Paolo Centomo; Massimo Carraro; Sandro Campestrini; Karel Jerabek; Benedetto Corain
Advanced Synthesis & Catalysis | 2008
Rosaria Ciriminna; Massimo Carraro; Sandro Campestrini; Mario Pagliaro